Sysmex Corp (FRA:0YX)
€ 18.7 0.1 (0.54%) Market Cap: 12.02 Bil Enterprise Value: 11.80 Bil PE Ratio: 36.91 PB Ratio: 4.47 GF Score: 99/100

Q3 2020 Sysmex Corp Earnings Call Transcript

Feb 05, 2020 / NTS GMT
Release Date Price: €22 (+1.54%)
Yukio Nakajima
Sysmex Corporation - Senior Exec. Officer, Senior MD, CFO & Member of the Managing Board

This is Nakajima from Sysmex. Let me explain our financial results for the first 9 months of the fiscal year ending March 31, 2020.

Please turn to Page 2, financial highlights. The net sales were JPY 218.1 billion, up by 4.7%. Operating profit was JPY 40.4 billion, down by 5%. Net income was JPY 26.4 billion, down by 8.3%. Net sales were affected by the yen appreciation, but both Japan and overseas businesses grew to support the overall growth. Operating income. Despite the gross profit increase supported by the sales increase, the profit declined, affected by yen appreciation, increased SG&A by reinforcing sales structure outside of Japan and increased R&D spending due to a new bio-diagnostic reagent base.

Please turn to the left-bottom chart, foreign exchange. Yen appreciated against dollar by JPY 2.4; and euro, by JPY 8.4; and RMB, by JPY 8.1 compared to the previous year. The FX impact on sales was negative JPY 9.43 billion.

On operating income, it was negative

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot